Cameroonians now have possibilities of having the hepatitis “B” and “C” drugs at 50 and 80% cost reduction.

The information was revealed in Yaounde by the Minister of Public Health Andre Mama Fouda during a press conference.

He revealed that patients suffering from Hepatitis “C” genotype 2 will henceforth spend 450,000 FCFA for a 3 months treatment instead of 2 million FCFA in 2014 and 11 million FCFA in 2011.

Meanwhile the cost of treatment for Hepatitis “C” genotype 1 and 4 has reduced from 3 million (2014) to 1.5 milion.

The treatment of both stages of Hepatitis are due to last for three months instead of four months as in 2011 and 2014 and with a recovery rate of 95%.
The Minister also said that the prevalence rate of Hepatitis “B” in Cameroon stands at 11.9%,that is about 2 million persons and 1.0% for Hepatitis C that is about 200, 000 persons.

Cameroon is second after Egypt and among the 91 countries around the world to benefit from such a privileged offered by Labo Gene.